US Sinks Another USD 2.1 Billion Into A Potential Vaccine
New Delhi: Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19 vaccine to the United States as governments buy up supplies…
Share